Emdin CA, Khera AV, Klarin D, et al. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling. Circulation. 2018;137(3):222-232. doi:10.1161/CIRCULATIONAHA.117.028021
Hong S, Stevens B. TREM2: Keeping Microglia Fit during Good Times and Bad. Cell Metab. 2017;26(4):590-591. doi:10.1016/j.cmet.2017.09.010
Garone C, D’Souza AR, Dallabona C, et al. Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome. Hum Mol Genet. 2017;26(21):4257-4266. doi:10.1093/hmg/ddx314
Yates M, Vasudevan PC, Chandler KE, et al. De novo mutations in HNRNPU result in a neurodevelopmental syndrome. Am J Med Genet A. 2017;173(11):3003-3012. doi:10.1002/ajmg.a.38492
Nishimasu H, Yamano T, Gao L, Zhang F, Ishitani R, Nureki O. Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1. Mol Cell. 2017;67(1):139-147.e2. doi:10.1016/j.molcel.2017.04.019
Alami NH, Smith RB, Carrasco MA, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536-543. doi:10.1016/j.neuron.2013.12.018
Tripathi P, Rodriguez-Muela N, Klim JR, et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-β1. Stem Cell Reports. 2017;9(2):667-680. doi:10.1016/j.stemcr.2017.06.008
Aguirre AJ, Hahn WC. Synthetic Lethal Vulnerabilities in -Mutant Cancers. Cold Spring Harb Perspect Med. 2018;8(8). doi:10.1101/cshperspect.a031518
Chen Q, Cichon J, Wang W, et al. Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron. 2012;76(2):297-308. doi:10.1016/j.neuron.2012.07.011
Johnson CP, Kim IK, Esmaeli B, et al. Systematic genomic and translational efficiency studies of uveal melanoma. PLoS One. 2017;12(6):e0178189. doi:10.1371/journal.pone.0178189